Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STA-9090 in Metastatic Breast Cancer
NCT01273896Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jan 2011
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ganetespib in breast cancer, sponsored by Memorial Sloan Kettering Cancer Center. Started Jan 2011; status: completed.
02
Drugs
ganetespib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01273896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01273896.